Replies to post #3847 on GTC Biotherapeutics (fka GTCB)

[ThomasS]

Flo, Did I miss something? Wasn't Merrimack going to present data on MM093 this past week, or, was that modified due to the new dosing regime?

[mouton29]

"I'll contact my contact & contact the board next week with the contact info on psoriasis :-"

Did you ever hear anything? I note the April 2006 press release annoucing completion of enrollment said the results of the psoriasis phase II would be available in late summer 2006 but I don't see any press releases or discussion of those results.

I ask because I have a resource in psoriasis research who might know something and might be willing to share. I don't want to bother if the program is dead.